Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Other Operating Expenses (2016 - 2025)

Updated

Avenue Therapeutics (ATXI) reported Other Operating Expenses of -$203,000 for Q4 2025.

Analysis

Avenue Therapeutics (ATXI) Other Operating Expenses (2016 - 2025) Analysis & Trends

  • The Q4 2025 figure ranks as the highest quarterly Other Operating Expenses since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -203,000.00
Dec 31, 2017 1.10 Mn
Dec 31, 2016 49,000.00
API Access

Avenue Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ATXI&period=max&api_key=YOUR_API_KEY